RecruitingNCT06965166

Contrast-Enhanced Photon-Counting Detector CT (PCD-CT) for the Local Staging of Rectal Cancer

Pilot Prospective Study of Contrast-Enhanced Photon-Counting Detector CT (PCD-CT) for the Local Staging of Rectal Cancer


Sponsor

Mayo Clinic

Enrollment

200 participants

Start Date

Oct 7, 2024

Study Type

OBSERVATIONAL

Conditions

Summary

This study evaluates whether images taken using a photon counting detector CT scanner (PCD-CT) can determine the growth of rectal cancer as well as, or better than, MRI for the management of patients with rectal cancer.


Eligibility

Min Age: 18 YearsMax Age: 99 Years

Plain Language Summary

Simplified for easier understanding

This study is testing a new type of CT scan (using photon-counting detector technology) to see how accurately it can stage rectal cancer — meaning how well it can tell doctors how far the cancer has spread locally — compared to standard MRI. **You may be eligible if...** - You are between 18 and 99 years old - You have a confirmed diagnosis of rectal cancer and are scheduled for standard staging scans (MRI and CT) - Your tumor is at least 2 cm in size - You are willing and able to sign a consent form - If you could be pregnant, you have had a negative pregnancy test **You may NOT be eligible if...** - You cannot receive intravenous contrast dye (e.g., due to severe allergy or kidney problems) - You are pregnant Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

PROCEDUREPCD-CT

Participants undergo PCD-CT scan on study


Locations(1)

Mayo Clinic in Rochester

Rochester, Minnesota, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06965166


Related Trials